# ğŸ¨ DESIGNER: Treatment History Timeline Chart (REVISED)

**Page:** Protocol Detail - Patient Treatment Timeline  
**Date:** 2026-02-10 (Updated)  
**Status:** DESIGN PROPOSAL - Awaiting Review  
**Role:** DESIGNER (No code implementation, specifications only)

---

## ğŸ¯ Design Objective (REVISED)

**User's Vision:**
> "Patient gets treatment on Day 1, returns on Day 8 for different treatment with slightly different outcomes, returns on Day 11 for another treatment, and so on. Horizontal timeline represented in a **chart** that adjusts dynamically depending on how many treatments the patient has."

**Placement:**
- **Between** Receptor Affinity Profile container and Therapeutic Envelope container
- Replaces nothing, inserts as new section

**Design Goal:**  
Create a **dynamic horizontal timeline chart** that:
- âœ… Shows precise day intervals (Day 1 â†’ Day 8 â†’ Day 11)
- âœ… Scales dynamically (2 treatments vs 10+ treatments)
- âœ… Displays outcome changes at each treatment point
- âœ… Supports complex filtering/analysis
- âœ… Works on screen AND print (1 page)
- âœ… Uses high-contrast, colorblind-friendly design

---

## ğŸ“Š Current Page Structure

### **Existing Layout (ProtocolDetail.tsx):**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ IDENTITY HEADER                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ LEFT PANEL (2/3)          â”‚ RIGHT PANEL (1/3)          â”‚
â”‚                            â”‚                            â”‚
â”‚ 1. Receptor Affinity       â”‚ 4. Protocol Architecture   â”‚
â”‚    Profile (Radar Chart)   â”‚    (Substance/Dosage)      â”‚
â”‚                            â”‚                            â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚                            â”‚
â”‚ â”‚ ğŸ†• TREATMENT TIMELINE   â”‚â”‚                            â”‚
â”‚ â”‚ (INSERT HERE)           â”‚â”‚                            â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚                            â”‚
â”‚                            â”‚                            â”‚
â”‚ 2. Therapeutic Envelope    â”‚ 5. Safety Monitor          â”‚
â”‚    (Setting/Timeline)      â”‚    (Meds/Events)           â”‚
â”‚                            â”‚                            â”‚
â”‚ 3. Efficacy Trajectory     â”‚                            â”‚
â”‚    (PHQ-9 Chart)           â”‚                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Insertion Point:** After Receptor Affinity Profile, before Therapeutic Envelope

---

## ğŸ“Š Current State Analysis

### **What Exists:**
- âœ… Single protocol detail view (shows ONE protocol at a time)
- âœ… Efficacy trajectory chart (PHQ-9 over time for ONE protocol)
- âœ… Receptor affinity radar
- âœ… Safety monitoring
- âœ… Print-optimized layout

### **What's Missing:**
- âŒ **Multi-protocol timeline** (no way to see sequential treatments)
- âŒ **Day-level temporal precision** (only dates, not day intervals)
- âŒ **Dynamic scaling** (chart doesn't adapt to number of treatments)
- âŒ **Treatment pattern detection** (no visual for dose escalation, substance rotation)
- âŒ **Filtering/analysis tools** (no way to filter by substance, outcome, etc.)

---

## ğŸ¨ Proposed Design: "Treatment Journey Timeline"

### **Visual Metaphor:**
A **horizontal timeline** showing protocols as **milestone cards** connected by **outcome trend lines**.

### **Layout Structure:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PATIENT TREATMENT JOURNEY                                    [Print Button] â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”         â”Œâ”€â”€â”€â”€â”€â”€â”         â”Œâ”€â”€â”€â”€â”€â”€â”         â”Œâ”€â”€â”€â”€â”€â”€â”              â”‚
â”‚  â”‚ P1   â”‚â”€â”€â”€â”€â”€â”€â”€â”€â–¶â”‚ P2   â”‚â”€â”€â”€â”€â”€â”€â”€â”€â–¶â”‚ P3   â”‚â”€â”€â”€â”€â”€â”€â”€â”€â–¶â”‚ P4   â”‚              â”‚
â”‚  â”‚25mg  â”‚  +12%   â”‚50mg  â”‚  +18%   â”‚50mg  â”‚  +5%    â”‚25mg  â”‚              â”‚
â”‚  â”‚Psilo â”‚         â”‚Psilo â”‚         â”‚MDMA  â”‚         â”‚Psilo â”‚              â”‚
â”‚  â”‚      â”‚         â”‚      â”‚         â”‚      â”‚         â”‚      â”‚              â”‚
â”‚  â”‚PHQ:18â”‚         â”‚PHQ:15â”‚         â”‚PHQ:12â”‚         â”‚PHQ:11â”‚              â”‚
â”‚  â””â”€â”€â”¬â”€â”€â”€â”˜         â””â”€â”€â”¬â”€â”€â”€â”˜         â””â”€â”€â”¬â”€â”€â”€â”˜         â””â”€â”€â”¬â”€â”€â”€â”˜              â”‚
â”‚     â”‚                â”‚                â”‚                â”‚                    â”‚
â”‚  Jan 15          Mar 22          Jun 10          Sep 5                      â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚  â”‚                    OUTCOME TREND LINE (PHQ-9)                         â”‚  â”‚
â”‚  â”‚  18 â—â”€â”€â”€â”€â”€â”€â”€â”€â”€â—15â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â—12â”€â”€â”€â”€â”€â”€â”€â”€â”€â—11                            â”‚  â”‚
â”‚  â”‚     â†“ -17%    â†“ -20%       â†“ -8%                                      â”‚  â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚  KEY INSIGHTS:                                                               â”‚
â”‚  âœ“ 4 sessions over 8 months                                                 â”‚
â”‚  âœ“ 39% total symptom reduction (PHQ-9: 18â†’11)                              â”‚
â”‚  âœ“ Best response: Protocol 2 (Psilocybin 50mg, -20%)                       â”‚
â”‚  âš  Substance switch at Protocol 3 (MDMA trial)                             â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ§© Component Breakdown

### **1. Timeline Header**
**Purpose:** Context and navigation

**Elements:**
- Patient hash (anonymized ID)
- Total treatment duration (e.g., "8 months")
- Number of protocols (e.g., "4 sessions")
- Print button (screen only)

**Visual Style:**
- Dark background: `bg-[#0b0e14]`
- White text: `text-white`
- Print: `print:bg-white print:text-black`

---

### **2. Protocol Milestone Cards**
**Purpose:** Show individual protocol details at a glance

**Card Contents:**
- **Protocol number** (P1, P2, P3...)
- **Substance name** (Psilocybin, MDMA, Ketamine)
- **Dosage** (25mg, 50mg, 100mg)
- **Route** (Oral, IV, IM) - icon only
- **PHQ-9 score** (baseline for this session)
- **Date** (Jan 15, 2024)
- **Outcome delta** (% change from previous session)

**Visual Design:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  P2                 â”‚ â† Protocol number (top-left)
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ Psilocybin  â”‚    â”‚ â† Substance (large, bold)
â”‚  â”‚ 50mg        â”‚    â”‚ â† Dosage (medium)
â”‚  â”‚ ğŸ’Š Oral     â”‚    â”‚ â† Route (icon + text)
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                     â”‚
â”‚  PHQ-9: 15          â”‚ â† Outcome score (large)
â”‚  â†“ -20% from P1     â”‚ â† Delta (color-coded)
â”‚                     â”‚
â”‚  Mar 22, 2024       â”‚ â† Date (bottom)
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Color Coding (Colorblind-Safe):**
- **Improvement (â†“):** Green dot + down arrow `â—â†“`
- **Worsening (â†‘):** Red dot + up arrow `â—â†‘`
- **No change (â†’):** Gray dot + right arrow `â—â†’`

**Card Styling:**
- Screen: `bg-slate-900 border-slate-800 rounded-2xl p-6`
- Print: `bg-white border-black rounded-lg p-4`
- Hover: `hover:border-primary/50 hover:shadow-xl` (screen only)

---

### **3. Connecting Arrows**
**Purpose:** Show temporal flow and outcome direction

**Visual Design:**
- **Arrow style:** Solid line with arrowhead `â”€â”€â”€â”€â”€â”€â”€â”€â–¶`
- **Color:** 
  - Improvement: `text-clinical-green` (green)
  - Worsening: `text-red-500` (red)
  - Neutral: `text-slate-600` (gray)
- **Label:** Outcome delta percentage above arrow
  - Example: `+12%` (improvement)
  - Example: `-5%` (worsening)

**Print Optimization:**
- Arrows become simple lines: `â”€â”€â”€â”€â”€`
- Delta text remains visible

---

### **4. Outcome Trend Line**
**Purpose:** Show longitudinal PHQ-9 progression across all protocols

**Visual Design:**
- **Chart type:** Line chart (Recharts AreaChart)
- **X-axis:** Protocol dates (Jan 15, Mar 22, Jun 10, Sep 5)
- **Y-axis:** PHQ-9 score (0-27)
- **Reference line:** Remission threshold (PHQ-9 < 5) - green dashed line
- **Data points:** Large dots at each protocol milestone
- **Gradient fill:** Blue gradient under the line

**Print Optimization:**
- Remove gradient fill (solid line only)
- Increase line thickness: `strokeWidth={3}`
- High-contrast colors: Black line, white background
- Remove grid (too busy for print)

**Chart Dimensions:**
- Screen: `h-[200px]`
- Print: `h-[120px]` (condensed)

---

### **5. Key Insights Panel**
**Purpose:** Summarize treatment journey in plain language

**Insights to Display:**
- âœ“ **Total sessions:** "4 sessions over 8 months"
- âœ“ **Overall improvement:** "39% symptom reduction (PHQ-9: 18â†’11)"
- âœ“ **Best response:** "Protocol 2 (Psilocybin 50mg, -20%)"
- âš  **Notable events:** "Substance switch at Protocol 3 (MDMA trial)"
- âš  **Safety flags:** "1 adverse event (Grade 2, resolved)"

**Visual Style:**
- Checkmark icon `âœ“` for positive insights (green)
- Warning icon `âš ` for notable events (amber)
- Alert icon `âš ` for safety flags (red)
- Text: `text-sm font-medium text-slate-300`
- Print: `text-[11px] text-black`

---

## ğŸ“ Layout Specifications

### **Screen Layout (Desktop):**

**Container:**
- `PageContainer width="wide"`
- `max-w-[1600px]`
- `px-6 sm:px-8 xl:px-10`

**Grid Structure:**
```tsx
<div className="space-y-8">
  {/* Timeline Header */}
  <div className="flex justify-between items-center">
    <h2>Patient Treatment Journey</h2>
    <button>Print</button>
  </div>

  {/* Protocol Timeline (Horizontal Scroll on Mobile) */}
  <div className="overflow-x-auto">
    <div className="flex gap-6 min-w-max">
      {protocols.map(protocol => (
        <ProtocolCard key={protocol.id} {...protocol} />
      ))}
    </div>
  </div>

  {/* Outcome Trend Chart */}
  <div className="bg-slate-900 border border-slate-800 rounded-3xl p-8">
    <OutcomeTrendChart data={protocols} />
  </div>

  {/* Key Insights */}
  <div className="bg-slate-900/50 border border-slate-800 rounded-2xl p-6">
    <KeyInsights protocols={protocols} />
  </div>
</div>
```

**Responsive Behavior:**
- **Desktop (>1024px):** All cards visible, horizontal layout
- **Tablet (768-1024px):** Horizontal scroll for timeline
- **Mobile (<768px):** Vertical stack (cards stack vertically)

---

### **Print Layout (Single Page):**

**Page Settings:**
```css
@media print {
  @page {
    size: letter landscape; /* 11" x 8.5" */
    margin: 0.5in;
  }
}
```

**Layout Adjustments:**
1. **Remove decorative elements:**
   - Background gradients
   - Hover effects
   - Navigation buttons
   - Tooltips

2. **Condense spacing:**
   - Card padding: `p-6` â†’ `p-3`
   - Gap between cards: `gap-6` â†’ `gap-3`
   - Chart height: `h-[200px]` â†’ `h-[100px]`

3. **Force high contrast:**
   - All text: `text-black`
   - All backgrounds: `bg-white`
   - All borders: `border-black`

4. **Fit to page:**
   - Timeline: Shrink cards to fit 4-6 protocols on one row
   - Chart: Reduce height, remove legend
   - Insights: Condense to 3-4 bullet points

**Print-Specific Classes:**
```css
.print:hidden { display: none !important; }
.print:bg-white { background: white !important; }
.print:text-black { color: black !important; }
.print:border-black { border-color: black !important; }
```

---

## ğŸ¨ Visual Design System

### **Color Palette (Colorblind-Safe):**

| Element | Screen Color | Print Color | Purpose |
|---------|-------------|-------------|---------|
| **Improvement** | `#10b981` (green) | `#000` (black) + `â†“` | Positive outcome |
| **Worsening** | `#ef4444` (red) | `#000` (black) + `â†‘` | Negative outcome |
| **Neutral** | `#64748b` (slate) | `#666` (gray) | No change |
| **Primary** | `#2b74f3` (blue) | `#000` (black) | Emphasis |
| **Background** | `#0b0e14` (dark) | `#fff` (white) | Container |
| **Text** | `#f1f5f9` (white) | `#000` (black) | Body text |
| **Border** | `#1e293b` (slate) | `#000` (black) | Dividers |

### **Typography:**

| Element | Screen | Print | Font Weight |
|---------|--------|-------|-------------|
| **Page Title** | `text-3xl` (30px) | `text-2xl` (24px) | `font-black` (900) |
| **Card Title** | `text-xl` (20px) | `text-lg` (18px) | `font-black` (900) |
| **Substance** | `text-2xl` (24px) | `text-xl` (20px) | `font-bold` (700) |
| **Dosage** | `text-lg` (18px) | `text-base` (16px) | `font-bold` (700) |
| **PHQ-9 Score** | `text-4xl` (36px) | `text-2xl` (24px) | `font-black` (900) |
| **Date** | `text-sm` (14px) | `text-xs` (12px) | `font-medium` (500) |
| **Delta %** | `text-base` (16px) | `text-sm` (14px) | `font-bold` (700) |
| **Insights** | `text-sm` (14px) | `text-[11px]` (11px) | `font-medium` (500) |

**Minimum Font Size:** 11px (per user rules, no fonts â‰¤ 9pt)

### **Spacing:**

| Element | Screen | Print |
|---------|--------|-------|
| **Card padding** | `p-6` (24px) | `p-3` (12px) |
| **Card gap** | `gap-6` (24px) | `gap-3` (12px) |
| **Section spacing** | `space-y-8` (32px) | `space-y-4` (16px) |
| **Border radius** | `rounded-2xl` (16px) | `rounded-lg` (8px) |

---

## ğŸ” Interaction Design

### **Screen Interactions:**

1. **Hover on Protocol Card:**
   - Border color changes: `border-slate-800` â†’ `border-primary/50`
   - Shadow appears: `shadow-xl`
   - Cursor: `cursor-pointer`
   - **Action:** Click to view full protocol detail

2. **Click on Connecting Arrow:**
   - Highlight both connected protocols
   - Show delta calculation tooltip
   - **Action:** Compare two protocols side-by-side (future feature)

3. **Hover on Trend Chart Data Point:**
   - Show tooltip with:
     - Protocol number
     - PHQ-9 score
     - Date
     - % change from previous

4. **Print Button:**
   - Opens browser print dialog
   - Automatically switches to print layout
   - **Action:** `window.print()`

### **Mobile Interactions:**

1. **Horizontal Scroll:**
   - Timeline cards scroll horizontally
   - Snap to card edges (CSS scroll-snap)
   - Swipe gesture support

2. **Tap on Card:**
   - Navigate to full protocol detail
   - No hover effects (touch-only)

---

## ğŸ“Š Data Requirements

### **Data Structure:**

```typescript
interface TreatmentHistory {
  patientId: string;
  patientHash: string;
  protocols: Protocol[];
  totalDuration: number; // days
  overallImprovement: number; // % change in PHQ-9
}

interface Protocol {
  id: string;
  protocolNumber: number; // 1, 2, 3, 4...
  substance: string;
  dosage: number;
  dosageUnit: string;
  route: string;
  date: string; // ISO 8601
  phq9Baseline: number;
  phq9Endpoint: number;
  deltaFromPrevious: number; // % change
  safetyEvents: SafetyEvent[];
  status: 'Active' | 'Completed';
}
```

### **Calculations:**

1. **Delta from Previous:**
   ```
   delta = ((current_phq9 - previous_phq9) / previous_phq9) * 100
   ```
   - Negative delta = improvement (PHQ-9 decreased)
   - Positive delta = worsening (PHQ-9 increased)

2. **Overall Improvement:**
   ```
   improvement = ((first_phq9 - last_phq9) / first_phq9) * 100
   ```

3. **Best Response:**
   - Protocol with largest negative delta

4. **Treatment Duration:**
   ```
   duration = last_protocol_date - first_protocol_date
   ```

---

## ğŸ–¨ï¸ Print Optimization Strategy

### **Goal:** Fit entire treatment history on 1 page (landscape)

### **Techniques:**

1. **Landscape Orientation:**
   - More horizontal space for timeline
   - Fits 4-6 protocol cards comfortably

2. **Condensed Layout:**
   - Remove all decorative elements
   - Reduce padding/margins by 50%
   - Shrink chart height

3. **High Contrast:**
   - Black text on white background
   - Thick borders (2px minimum)
   - No gradients or shadows

4. **Essential Information Only:**
   - Hide navigation buttons
   - Hide tooltips
   - Hide "Cohort Matches" section
   - Keep only: Timeline, Chart, Key Insights

5. **Page Break Control:**
   ```css
   .print:break-inside-avoid {
     break-inside: avoid;
   }
   ```
   - Prevent cards from splitting across pages
   - Keep chart on same page as timeline

6. **Font Size Adjustments:**
   - Reduce all fonts by 2-4px
   - Maintain minimum 11px (per user rules)

---

## ğŸ“ Example Layout (4 Protocols)

### **Screen View:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PATIENT TREATMENT JOURNEY                          [Print Record]      â”‚
â”‚ 6f9a2b3c4d5e... â€¢ 4 Sessions â€¢ 8 Months                                â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚  â”‚    P1    â”‚â”€â”€â”€â”€â”€â”€â–¶â”‚    P2    â”‚â”€â”€â”€â”€â”€â”€â–¶â”‚    P3    â”‚â”€â”€â”€â”€â”€â”€â–¶â”‚    P4    â”‚â”‚
â”‚  â”‚          â”‚ -17%  â”‚          â”‚ -20%  â”‚          â”‚ -8%   â”‚          â”‚â”‚
â”‚  â”‚Psilocybinâ”‚       â”‚Psilocybinâ”‚       â”‚   MDMA   â”‚       â”‚Psilocybinâ”‚â”‚
â”‚  â”‚  25mg    â”‚       â”‚  50mg    â”‚       â”‚  100mg   â”‚       â”‚  25mg    â”‚â”‚
â”‚  â”‚  ğŸ’Š Oral â”‚       â”‚  ğŸ’Š Oral â”‚       â”‚  ğŸ’‰ IV   â”‚       â”‚  ğŸ’Š Oral â”‚â”‚
â”‚  â”‚          â”‚       â”‚          â”‚       â”‚          â”‚       â”‚          â”‚â”‚
â”‚  â”‚ PHQ-9: 18â”‚       â”‚ PHQ-9: 15â”‚       â”‚ PHQ-9: 12â”‚       â”‚ PHQ-9: 11â”‚â”‚
â”‚  â”‚          â”‚       â”‚          â”‚       â”‚          â”‚       â”‚          â”‚â”‚
â”‚  â”‚Jan 15 '24â”‚       â”‚Mar 22 '24â”‚       â”‚Jun 10 '24â”‚       â”‚Sep 5 '24 â”‚â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                         â”‚
â”‚  OUTCOME TREND (PHQ-9 Depression Scale)                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ 27â”‚                                                              â”‚  â”‚
â”‚  â”‚   â”‚                                                              â”‚  â”‚
â”‚  â”‚ 18â”‚â—â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                   â”‚  â”‚
â”‚  â”‚   â”‚ â•²                                                            â”‚  â”‚
â”‚  â”‚ 15â”‚  â—â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                  â”‚  â”‚
â”‚  â”‚   â”‚   â•²                                                          â”‚  â”‚
â”‚  â”‚ 12â”‚    â—â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                               â”‚  â”‚
â”‚  â”‚   â”‚     â•²                                                        â”‚  â”‚
â”‚  â”‚ 11â”‚      â—                                                       â”‚  â”‚
â”‚  â”‚  5â”‚- - - - - - - - - - - - - - - - - - - - - - - - (Remission) â”‚  â”‚
â”‚  â”‚  0â”‚                                                              â”‚  â”‚
â”‚  â”‚   â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚  â”‚
â”‚  â”‚        Jan 15  Mar 22  Jun 10  Sep 5                            â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                         â”‚
â”‚  KEY INSIGHTS                                                           â”‚
â”‚  âœ“ 4 sessions over 8 months (avg 2 months between sessions)           â”‚
â”‚  âœ“ 39% total symptom reduction (PHQ-9: 18 â†’ 11)                       â”‚
â”‚  âœ“ Best response: Protocol 2 (Psilocybin 50mg, -20% improvement)      â”‚
â”‚  âš  Substance switch at Protocol 3 (MDMA trial, -8% improvement)       â”‚
â”‚  âš  1 adverse event (Protocol 3, Grade 2 Nausea, resolved)             â”‚
â”‚  âš  Approaching remission threshold (PHQ-9 < 5)                        â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### **Print View (Condensed):**

```
PATIENT TREATMENT JOURNEY
6f9a2b3c4d5e... â€¢ 4 Sessions â€¢ 8 Months

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  P1    â”‚â”€â”€â”€â”€â–¶â”‚  P2    â”‚â”€â”€â”€â”€â–¶â”‚  P3    â”‚â”€â”€â”€â”€â–¶â”‚  P4    â”‚
â”‚Psilo   â”‚-17% â”‚Psilo   â”‚-20% â”‚MDMA    â”‚-8%  â”‚Psilo   â”‚
â”‚25mg    â”‚     â”‚50mg    â”‚     â”‚100mg   â”‚     â”‚25mg    â”‚
â”‚PHQ:18  â”‚     â”‚PHQ:15  â”‚     â”‚PHQ:12  â”‚     â”‚PHQ:11  â”‚
â”‚Jan 15  â”‚     â”‚Mar 22  â”‚     â”‚Jun 10  â”‚     â”‚Sep 5   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â””â”€â”€â”€â”€â”€â”€â”€â”€â”˜

OUTCOME TREND (PHQ-9)
 18 â—â”€â”€â”€â”€â—15â”€â”€â”€â”€â—12â”€â”€â”€â”€â—11
    â†“17%  â†“20%  â†“8%
- - - - - - - - - - - - - - - (Remission < 5)

KEY INSIGHTS
âœ“ 39% total symptom reduction (PHQ-9: 18â†’11)
âœ“ Best response: P2 (Psilocybin 50mg, -20%)
âš  Substance switch at P3 (MDMA trial)
âš  1 adverse event (P3, Grade 2, resolved)
```

---

## âœ… Design Checklist

### **Accessibility:**
- [ ] Minimum 11px font size (per user rules)
- [ ] Color + icon/text for all status indicators (colorblind-safe)
- [ ] High contrast in print mode (black on white)
- [ ] Keyboard navigation support (Tab, Enter, Escape)
- [ ] Screen reader friendly (ARIA labels)

### **Responsiveness:**
- [ ] Desktop: Horizontal timeline, all cards visible
- [ ] Tablet: Horizontal scroll for timeline
- [ ] Mobile: Vertical stack or horizontal scroll
- [ ] Print: Landscape, fits on 1 page

### **Print Optimization:**
- [ ] Landscape orientation
- [ ] Remove decorative elements
- [ ] High contrast (black/white)
- [ ] Condensed spacing
- [ ] Essential information only
- [ ] No page breaks within cards

### **Data Integrity:**
- [ ] Accurate delta calculations
- [ ] Correct temporal ordering
- [ ] Safety event flags visible
- [ ] Substance switches highlighted

---

## ğŸš€ Implementation Handoff (For INVESTIGATOR)

### **Files to Modify:**
1. `src/pages/ProtocolDetail.tsx` - Add treatment history timeline section
2. `src/components/ProtocolCard.tsx` - New component for protocol milestone cards
3. `src/components/charts/OutcomeTrendChart.tsx` - New chart component
4. `src/types.ts` - Add `TreatmentHistory` interface

### **New Components Needed:**
1. **`ProtocolCard.tsx`** - Individual protocol milestone card
2. **`OutcomeTrendChart.tsx`** - Longitudinal PHQ-9 chart
3. **`TreatmentTimeline.tsx`** - Main timeline container
4. **`KeyInsights.tsx`** - Insights summary panel

### **Data Fetching:**
- Query: Fetch all protocols for a given `patientHash`
- Sort: Order by `date` ascending
- Calculate: Deltas, overall improvement, best response

### **Testing Requirements:**
- [ ] Test with 2 protocols (minimum)
- [ ] Test with 6+ protocols (horizontal scroll)
- [ ] Test print layout (landscape, 1 page)
- [ ] Test on mobile (vertical stack or scroll)
- [ ] Test with colorblind simulator

---

## ğŸ“ Open Questions for Review

1. **Timeline Orientation:**
   - Horizontal (left-to-right) or Vertical (top-to-bottom)?
   - **Recommendation:** Horizontal (better for temporal flow)

2. **Card Size:**
   - Fixed width (e.g., 200px) or Flexible (responsive)?
   - **Recommendation:** Fixed width for consistency

3. **Mobile Behavior:**
   - Horizontal scroll or Vertical stack?
   - **Recommendation:** Horizontal scroll (preserves timeline metaphor)

4. **Print Page Limit:**
   - How many protocols should fit on 1 page?
   - **Recommendation:** 4-6 protocols (landscape)

5. **Outcome Metric:**
   - PHQ-9 only or support multiple scales (GAD-7, etc.)?
   - **Recommendation:** Start with PHQ-9, add others later

---

## ğŸ¯ Success Metrics

**This design will be successful if:**
1. âœ… Practitioners can see entire treatment history at a glance
2. âœ… Temporal relationships are immediately clear
3. âœ… Outcome trends are visually obvious
4. âœ… Print layout fits on 1 page (landscape)
5. âœ… Design is colorblind-friendly (no color-only meaning)
6. âœ… Mobile experience is usable (scroll or stack)

---

**DESIGNER ROLE COMPLETE**  
**Next Step:** INVESTIGATOR review and approval before handoff to BUILDER

**Awaiting User Feedback:**
- Approve design concept?
- Prefer horizontal or vertical timeline?
- Any additional insights to display?
- Print layout acceptable?
